Abbott Says Humira Gained Market Share in Crohn's, Psoriasis - Bloomberg

Kansas City prima Abbott Says Humira Gained Market Share in Crohn's, Psoriasis Bloomberg Photographer: Tim Boyle/Bloomberg Revenue from Abbott Laboratories (ABT)' top-selling drug, Humira, surged 25 per centum after wresting sales from rival treatments for disease of the skin and Crohn's disease, primary Financial Officer Thomas Freyman said. ... Abbott Says Humira Gained Market stock in Crohn's, Psoriasis San Francisco Chronicle Abbott enjoys strong growth at pharmaceutical company unit Pharma Times Abbott Labs 2Q profit grows with emerging markets The Associated Press Proactive Investors USA & Canada each 201 news articles » Link To Article